Efficacy and safety of Nrf2 activators for schizophrenia: a systematic review and meta-analysis.

Eur Arch Psychiatry Clin NeurosciMay 19, 2026 (epub)
Clinical ResearchPsychiatryOpen access

Masakazu Okazaki, Kenji Sakuma, Hikaru Jo et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis evaluated the efficacy and safety of Nrf2 activators in conjunction with antipsychotic treatments for schizophrenia, involving 16 randomized-controlled trials with 953 participants. Curcumin demonstrated marginal superiority over placebo for overall symptom improvement (standardized mean difference = -0.53), while sulforaphane was associated with a lower all-cause discontinuation rate compared to placebo.

Key findings

  • Curcumin showed a standardized mean difference of -0.53 for overall symptom improvement compared to placebo.
  • Sulforaphane resulted in a lower all-cause discontinuation rate than placebo.
  • Curcumin significantly reduced positive and negative symptoms and PANSS-G scores compared to placebo.
  • Sulforaphane decreased total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels.

Why it matters

Understanding the efficacy and safety of adjunctive Nrf2 activators can inform treatment strategies for schizophrenia, particularly in enhancing symptom management and improving patient adherence to therapy.

Source

Published in Eur Arch Psychiatry Clin Neurosci. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.